High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator

OncoImmunology

Volumn 1, Issue 1, 2012, Pages 75-77

  Sorbye, Sveinung Wergeland ^a,b   Kilvaer, Thomas ^b   Valkov, Andrej ^a,b   Donnem, Tom ^a,b   Smeland, Eivind ^a   Al Shibli, Khalid ^b,c   Bremnes, Roy M ^a,b   Busund, Lill Tove ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

B lymphocytes; CD20; CD3; CD4; CD45; CD8; Soft tissue sarcomas; STS; T lymphocytes; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; INFANT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NOTE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT INDICATION;

EID: 84886943894     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.1.1.17825     Document Type: Note

References (8)

1. Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, et al. Prognostic impact of lymphocytes in soft tissue sarcomas. PLoS One 2011; 6:14611; DOI:10.1371/journal.pone.0014611.
2. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94:1-5; DOI:10.1002/ijc.1385.
3. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6:24-37; DOI:10.1038/nrc1782.
4. Mukai S, Kjaergaard J, Shu S, Plautz GE. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 1999; 59:5245-9.
5. Hong C, Lee H, Oh M, Kang CY, Hong S, Park SH. CD4+ T cells in the absence of the CD8+ cytotoxic T cells are critical and sufficient for NKT cell-dependent tumor rejection. J Immunol 2006; 177:6747-57.
6. Al Shibli KI, Donnem T, Al Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008; 14:5220-7.
7. Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favorable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 2009; 9:292; DOI:10.1186/1471-2407-9-292.
8. Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, et al. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006; 125:451-8; DOI:10.1309/15B66DQMFYYM78CJ.